SECUKINUMAB PROVIDES SUSTAINED REDUCTION IN FATIGUE IN PATIENTS WITH ANKYLOSING SPONDYLITIS THROUGH 3 YEARS: LONG-TERM RESULTS OF TWO RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDIES

被引:0
|
作者
Kvien, T. K. [1 ]
Deodhar, A. [2 ]
Gossec, L. [3 ]
Conaghan, P. G. [4 ]
Strand, V. [5 ]
Ostergaard, M. [6 ]
Williams, N. [7 ]
Porter, B. [8 ]
Gandhi, K. [8 ]
Jugl, S. [9 ]
机构
[1] Diakonhjemmet Hosp, Oslo, Norway
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] UPMC Univ Paris 06, Paris, France
[4] Univ Leeds, Leeds, W Yorkshire, England
[5] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
[6] Copenhagen Ctr Arthrit Res COPECARE, Glostrup, Denmark
[7] RTI Hlth Solut, Durham, NC USA
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
363
引用
收藏
页码:S9 / S9
页数:1
相关论文
共 50 条
  • [41] Impact of Fremanezumab on Disability Severity in Patients With Episodic and Chronic Migraine: Pooled Results of 3 Randomized, Double-blind, Placebo-controlled Phase 3 Studies
    Nagy, Abraham J.
    McAllister, Peter
    Cohen, Joshua M.
    Ning, Xiaoping
    Campos, Verena Ramirez
    Du, Evelyn
    Ashina, Messoud
    NEUROLOGY, 2021, 96 (15)
  • [42] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES
    Schett, Georg
    Baraliakos, Xenofon
    van den Bosch, Filip
    Deodhar, Atul
    Gensler, Lianne S.
    Ostergaard, Mikkel
    Agawane, Shital
    Das Gupta, Ayan
    Mpofu, Shephard
    Fox, Todd
    Winseck, Adam
    Shete, Abhijit
    Porter, Brian
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 873 - 874
  • [43] Improvements in Headache-Related Disability With Fremanezumab in Patients ≥60 Years of Age With Migraine: Pooled Results of 3 Randomized, Double-Blind, Placebo-Controlled Phase 3 Studies
    Joshi, S.
    Cohen, J. M.
    Ning, X.
    Ramirez-Campos, V
    Janka, L.
    Ashina, M.
    HEADACHE, 2020, 60 : 20 - 20
  • [44] Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial
    Duygu Şilte Karamanlioğlu
    Ilknur Aktas
    Feyza Unlu Ozkan
    Meryem Kaysin
    Nuray Girgin
    Rheumatology International, 2016, 36 : 653 - 661
  • [45] SECUKINUMAB REDUCES SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: RESULTS FROM A 16-WEEK, RANDOMIZED PLACEBO-CONTROLLED PHASE 3 TRIAL
    Kivitz, Alan
    Blanco, Ricardo
    Maradiaga, Marco
    Sieper, Joachim
    Tahir, Hasan
    Andersson, Mats
    Readie, Aimee
    Porter, Brian
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2016, 22 (03) : 141 - 141
  • [46] Efficacy and safety of AK111, in patients with active ankylosing spondylitis: results from a randomized, double-blind, placebo-controlled, phase II clinical study
    Li, Zhanguo
    Xia, Yu
    Wang, Max
    Li, Baiyong
    Ni, Xiang
    Wang, Guoqin
    Zhang, Li
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01)
  • [47] IMPACT OF FREMANEZUMAB ON DISABILITY SEVERITY IN PATIENTS WITH EPISODIC AND CHRONIC MIGRAINE: POOLED RESULTS OF 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDIES
    Nagy, Abraham J.
    McAllister, Peter
    Cohen, Joshua M.
    Ning, Xiaoping
    Campos, Verena Ramirez
    Du, Evelyn
    Ashina, Messoud
    CEPHALALGIA, 2020, 40 : 93 - 94
  • [48] Effectiveness of ultrasound treatment applied with exercise therapy on patients with ankylosing spondylitis: a double-blind, randomized, placebo-controlled trial
    Karamanlioglu, Duygu Silte
    Aktas, Ilknur
    Ozkan, Feyza Unlu
    Kaysin, Meryem
    Girgin, Nuray
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (05) : 653 - 661
  • [49] Efficacy and Safety of Wenbu Zhibi Granule in Patients with Ankylosing Spondylitis: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
    Zhang, Helou
    Yu, Yang
    Du, Weibin
    Wu, Fengqing
    Zheng, Yang
    Ren, Conglin
    Zhou, Huateng
    Wu, Yijiang
    Gao, Yang
    Ren, Weifan
    Quan, Renfu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [50] Dietary Nitrate Provides Sustained Blood Pressure Lowering in Hypertensive Patients A Randomized, Phase 2, Double-Blind, Placebo-Controlled Study
    Kapil, Vikas
    Khambata, Rayomand S.
    Robertson, Amy
    Caulfield, Mark J.
    Ahluwalia, Amrita
    HYPERTENSION, 2015, 65 (02) : 320 - U174